Phase 2 Classical Hodgkin Lymphoma Clinical Trials
10 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–10 of 10 trials
Recruiting
Phase 2Phase 3
Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment
TreatmentSurvivalClassical Hodgkin Lymphoma+6 more
Children's Cancer Group, China96 enrolled1 locationNCT06563245
Recruiting
Phase 1Phase 2
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
MelanomaSolid TumorLymphoma+2 more
Merck Sharp & Dohme LLC370 enrolled17 locationsNCT02332668
Recruiting
Phase 2
Chidamide Decitabine Plus Anti-PD-1 Antibody for Patients With R/R cHL Who Are Transplant-ineligible or Refused Transplant.
Ineligible Or Refused Transplant Patients With Classical Hodgkin Lymphoma
Chinese PLA General Hospital100 enrolled1 locationNCT06393361
Recruiting
Phase 2
Sintilimab Plus AVD in Pediatric Low/Moderate Risk Hodgkin Lymphoma: A Phase II Study
Classical Hodgkin Lymphoma
Sun Yat-sen University73 enrolled1 locationNCT06848569
Recruiting
Phase 2
Pembrolizumab in Combination With Salvage Chemotherapy for First-relapsed or Refractory Classical Hodgkin Lymphoma
Classical Hodgkin Lymphoma
University of Cologne29 enrolled1 locationNCT04838652
Recruiting
Phase 2
Phase II Trial of Individualized Immunotherapy in Early-Stage Unfavorable Classical Hodgkin Lymphoma
Classical Hodgkin Lymphoma
University of Cologne120 enrolled1 locationNCT04837859
Recruiting
Phase 2
Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above
Classical Hodgkin Lymphoma
University of Virginia44 enrolled3 locationsNCT05404945
Recruiting
Phase 2
Study of Pembrolizumab With Bendamustine in Hodgkin Lymphoma
Refractory CancerClassical Hodgkin LymphomaRelapsed Cancer
University Health Network, Toronto37 enrolled1 locationNCT04510636
Recruiting
Phase 2
A Study of Zimberelimab(GLS-010) Combined With AVD for Newly Diagnosed Early-stage Hodgkin's Lymphoma
Classical Hodgkin Lymphoma
Sun Yat-sen University54 enrolled1 locationNCT05900765
Recruiting
Phase 2
Brentuximab Vedotin Plus DHAP in Relapsed or Refractory Hodgkin's Lymphoma
Relapsed/Refractory Classical Hodgkin Lymphoma
National Cancer Center, Korea30 enrolled1 locationNCT05243693